SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: Ibexx who wrote (1674)4/27/1998 9:30:00 AM
From: Brian Malloy  Read Replies (1) | Respond to of 9523
 
VVUS did tank from a high of about $43 to single digits but I think it took about five months, I could be wrong.

I initially purchased March 30 VVUS options when the stock was at the $26 dollar level or so I believe. About a week or so later the Jeff Vilnick news came out and VVUS started rising and the day before earnings were announced stock hit $43. After earnings it was down to $40. I took a nice profit at that time, and recommended to a few others on the thread that they do the same. I played with a few shares from time to time but nothing big after that.

In March I recommended to people on the VVUS thread to buy June 90 PFE calls. Also during this time period I recommended that they hold off on buying VVUS until it hit about the eight dollar level.



To: Ibexx who wrote (1674)4/29/1998 2:38:00 AM
From: R. K. (Chip) Constantian Jr.  Respond to of 9523
 
"Miracle" potency pill is a hit with U.S. women too

By Maggie Fox, Health and Science Correspondent
Tuesday April 28, 9:21 pm Eastern Time

WASHINGTON, April 28 (Reuters) - Praised as a miracle drug for men, Viagra, the first pill for impotence, is also finding a market
among women, doctors and analysts said on Tuesday.

Nearly 150,000 prescriptions have been written for the drug since it went on the market in the United States this month. Many men
with sexual problems say it has offered them a new lease on life.

But doctors and pharmacists say they are getting plenty of queries from women as well -- and many are not asking on behalf of their
partners.

''A lot of women are interested,'' said Dr. Myron Murdoch, a urologist in Greenbelt, Maryland, who is national medical director for
the Impotence Institute of America.

''If you think there's a big demand for male sexual dysfunction medicine, wait until women find out they can have some sort of sexual
dysfunction medicine.''

In commercial terms, Pfizer's (PFE - news) drug is already a blockbuster. During its second week on the market, pharmacists sold
more than 113,000 new prescriptions for Viagra, known generically as sildenafil.

Hemant Shah, an independent drug analyst in New Jersey, said much of the demand was being driven by women.

''They (pharmacists) are telling me they can't keep it in stock and that both men and women are using it,'' he said.

Viagra is not approved for women. It was tested only in men and is designed to act as an ''arousal enhancer,'' getting blood to the
penis to help a man get an erection.

''We get a lot of inquiries as to women. This is absolutely inappropriate,'' said Dr. James Barada, a urologist in Albany, New York,
who helped draw up erectile dysfunction guidelines for the American Urological Association (AUA). ''It's so far off-label that it's
pathetic.''

But once a drug is approved, there is little to stop a doctor from writing an ''off-label'' or unapproved prescription for a woman,
though Viagra's makers stress there is as yet no evidence of any good reason to do so.

''This is a drug that has been approved for erectile dysfunction, which is obviously for men, and there is no scientific data to support its
use in women,'' said Pfizer spokeswoman Mariann Caprino.

Pfizer does have Phase II clinical safety tests underway in Europe in a group of women and some doctors see no reason not to
prescribe the drug to women.

Murdoch said the vagina and clitoris were made of the same tissue as the penis and a drug that improved blood flow in men would do
the same in women.

''Physiologically ... the clitoris is nothing more than a penis without a urethra,'' he said. The urethra carries urine and sperm in men.

''The drugs we are using for male sexual dysfunction, these drugs will be effective in causing increased blood flow in the vagina and in
the clitoris, so that women who have lack of lubrication, we can improve that.''

Murdoch said doctors could use drugs, including Viagra, to help women who were worried about losing interest in sex.

''Women who have arousal problems, we can stimulate that. The male hormone testosterone can improve desire in women.''

That could help relationships in general, he said. ''If you can do all this, it certainly should lead to an improvement in sexual
relationships between men and women.''

----------------------------------------------------------------------

Cool! Chip